Company: SXTPW
Filing Date: 2025-03-27
Form Type: 10-K
Source: 0001013762-25-003343
Chunk: 378

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-03-27
Form: 10-K
Item: Item 1A
Chunk 378
---
 total of 518 shares of common stock, of which includes (i) 234 shares of common stock held in the name of Mr. Allen, and (ii)
    284 shares underlying fully vested options exercisable into common stock at a per share exercise price of $318.00.

    (6)
    Ms. Xu beneficially owns
    a total of 4,100 shares of common stock, of which includes (i) 3,816 shares of common stock held in the name of Ms. Xu, and (ii)
    284 shares underlying fully vested options exercisable into common stock at a per share exercise price of $318.00.

    (7)
    Mr. Toovey beneficially
    owns a total of 518 shares of common stock, of which includes (i) 234 shares of common stock held in the name of Mr. Toovey, and
    (ii) 284 shares underlying fully vested options exercisable into common stock at a per share exercise price of $318.00.

    (8)
    Mr. Field beneficially
    owns a total of 518 shares of common stock, of which includes (i) 167 shares of common stock held by the Field Family Trust, of which
    Mr. Field is a trustee and has control over the voting and disposition of the shares of common stock held by the Field Family Trust,
    (ii) 67 shares of common stock held in the name of Mr. Field, and (iii) 284 shares underlying fully vested options exercisable into
    common stock at a per share exercise price of $318.00.

76

Equity Plan Information

See Part II, Item 5 “Market for Registrant’s
Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities” of this Annual Report on Form 10-K.

Changes in Control

There are no arrangements, to our knowledge,
including any pledge by any person of securities of the Company, the operation of which may at a subsequent date result in a change in
control of the Company.

Item 13. Certain Relationships
and Related Transactions, and Director Independence.

In March 2023, we received a $200,000 short term
advance from the Geoffrey S. Dow Revocable Trust. In April and May 2023, we received a $23,000 short term advance from the
Geoffrey S. Dow Revocable Trust and $27,000 from Tyrone Miller